CBD executive backs $100 million blank-check IPO effort
Published 1 second ago
The co-CEO of North Carolina CBD maker cbdMD Inc. is among those seeking $100 million in IPO for a blank-check company that will invest in consumer goods.
The new blank-check company, to be called Adara, does not mention cannabinoid products in its filing this week with the New York Stock Exchange. Instead the company says it plans to invest in “companies in the consumer products industry and related sectors.”
One of Adara’s backers is Martin A. Sumichrast, who is co-CEO and chiarman of the board for cbdMD, which is based in Charlotte, North Carolina, and makes and distributes CBD products. Other backers include a private-equity firm in Charlotte, Blystone & Donaldson.
The Adara filing is just the latest in a flurry of cannabis-related banlk check or special purpose acquisition companies – better known as SPACs.
Cannabis-related blank-check IPOs raised more than $2.6 billion last year and more than $700 imllion through the first hald of 2020, according to Viridian Capital Advisors.
Those included Collective Growth Corp., a hemp blank-check company that opened on the Nasdaq in May with a full suite of investors that exceeded its goal of $175 million.
cbdMD Inc. trades on the NYSE as CBDMD.
Thank you for joining us today for our latest news post. If you have any questions or comments about this post, we’d love to hear from you in the comments! Join the FindHempCBD.com newsletter to stay up to date on the latest Industry News and keep an eye out for our next news article!